Wageningen University received a subsidy of 12.5 million euros to create a vaccine against the mosquito borne virus Rift Valley Fever that is safe for humans. The subsidy comes from the Coalition for Epidemic Preparedness Innovation (CEPI), NOS reports.
After ten years of research and testing by the university hospitals in Leiden and Nijmegen, a malaria vaccine seems to be on the horizon. Tests on 19 human subjects in the Netherlands over the past six months seem to indicate a breakthrough. They were injected with genetically weakened malaria parasites and none of them got malaria, NOS reports.
The Radboud University Medical Center in Nijmegen is teaming up with Erasmus MC and the Haven hospital in Rotterdam for an experiment in using a parasite found in mice for a new malaria vaccine for humans. The first three volunteers were given a genetically modified rodent malaria as vaccine on Tuesday, the Telegraaf reports.
Professor Bart Haagmans and his team of scientists at the Erasmus Medical Center believe that they are one step closer to developing a vaccine that protects against the MERS virus. Their vaccine managed to protect camels from developing symptoms of the virus
After 17 years of research and hard work, researchers from the Amsterdam Academic Medical Center and the Cornell University in New York have take a major step in the process of developing a vaccine against the AIDS virus. They have managed to create a vaccine that work against two variants of the AIDS virus in animals.
Dutch drug manufacturer Janssen Pharmaceutical Companies started testing an Ebola vaccine on humans this week. The Johnson & Johnson subsidiary produced 400,000 doses of the vaccine for large-scale clinical trials that could launch by April, the firm said in a statement.
In Overijssel, two Municipal Healtcare Service's (GGD) in the region of Twente have reported a rise in cases of whooping cough. Nurses are warning those vaccinated that their cough might not be a nasty cold after all, RTV Oost reports.
A bio-tech company in Leiden is making headway developing a vaccine against the deadly, and fast-spreading ebola virus. In an interview with Het Financieele Dagblad, Maria Pau, head of the research program, says that data from tests on monkeys is very promising.
A new study conducted under leadership from UMC Utrecht has discovered that the chance for the elderly to develop lung infections can be greatly reduced by a vaccine.